Jazz Pharmaceuticals, Inc. (JAZZ)
A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.
Recs
Rumor has it JAZZ may taken over buy Forrest Labs
Recs
Insiders /Phase 111
Recs
Hm...............insider bought 1.5 million shares.
Recs
Japanese Candlestick
Recs
Great stock..new drug offering!!!
Recs
Earnings report last night. Good report.
Recs
http://seekingalpha.com/article/143384-fda-calendar-updates-transdel-javelin-jazz-par-pharma?source=feed
Recs
JAZZ Pharmaceuticals stopped playing the blues after Phase III data was released indicating it'ssodium oxybate (JZP-6) showed a statistically significant reduction in fibromyalgia pain. Since the drug is already marketed to treat narcolepsy (a chronic sleep disorder), the safety concern of the two major issues for approval, (safety and affectivity) should be minimal. JAZZ soard as high as $4.85 as is typical on drug stocks with good news lately. The pullback to the low $3's in my opinion is a gift. Yes drug stocks are highly volitile. Funding, results, approvals, all cause gyrations. It is becoming harder to buy a drug between Phase III and FDA approval/disapproval with a decent risk reward as speculators abound. I think JAZZ has a good valuation. To have only been in business since 2003, Jazz's portfolio of neurology and psychiatry drugs/candidates has some great potential. I'm JAZZ'd up on JAZZ.
Recs
this was too quick of a run. Especially only after a trail run.
Recs
Steep run up recently looks good for red thumb and their cash position is 1/3 of what it was 2 quarters ago

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 10 of 10